Aveeno Signs Partnership with Mayo Clinic

Aveeno has signed three-year collaboration with Mayo Clinic that will focus on research, education and innovation.

The research programs will include preclinical and clinical investigations to advance scientific research on the power of Aveeno’s “Triple Oat” for compromised skin, according to parent company Kenvue. Through research efforts that bring together dermatological research expertise and consumer skin health insights, Kenvue said the collaboration aims to advance skin wellness and education through its Aveeno portfolio.

“We are constantly pushing for innovation, staying on the cutting edge of research and testing, especially within our skin health portfolio,” said Dr. Caroline Tillett, chief scientific officer at Kenvue. “Aveeno was the first brand to formulate colloidal oatmeal, and we are thrilled at the opportunity to collaborate with Mayo Clinic’s multi-disciplinary physicians to enhance our understanding of skin health. We care fiercely for those who use and recommend our products, and our goal is to deliver even greater solutions for ultimate skin health and wellness for both patients and consumers.”